Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Environment
Immunicon cuts research staff
September 5, 2005
| A version of this story appeared in
Volume 83, Issue 36
Immunicon, a developer of diagnostic tools for cancer drug development, plans to cut its full-time staff by 25% to save money. The company, which had 139 employees at the end of last year, says most of the reduction involves research employees working on projects nearing completion, such as a cell analysis platform called CellTracks Analyzer. The firm has also completed development work on reagents and other components of a cell analysis kit for Johnson & Johnson's Veridex unit.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter